HOT Screen - The faster way to better drugs

From late failure to early success - 90 % of all clinical studies fail after usually 10+ years of highly expensive preclinical development.

HOT Screen´s goal is to make drug development faster, safer, less expensive and more reliable.

Our organotypic cell culture systems particularly help to reduce attrition rates in the later, clinical phases of drug development